326 related articles for article (PubMed ID: 29798889)
1. Incidence and Progression of Chronic Kidney Disease in Black and White Individuals with Type 2 Diabetes.
Gerber C; Cai X; Lee J; Craven T; Scialla J; Souma N; Srivastava A; Mehta R; Paluch A; Hodakowski A; Frazier R; Carnethon MR; Wolf MS; Isakova T
Clin J Am Soc Nephrol; 2018 Jun; 13(6):884-892. PubMed ID: 29798889
[TBL] [Abstract][Full Text] [Related]
2. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
[TBL] [Abstract][Full Text] [Related]
3. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 23 and incident CKD in type 2 diabetes.
Isakova T; Craven TE; Lee J; Scialla JJ; Xie H; Wahl P; Marcovina SM; Byington RP; Wolf M
Clin J Am Soc Nephrol; 2015 Jan; 10(1):29-38. PubMed ID: 25343949
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Incident CKD in Black and White Americans: The REGARDS Study.
Cheung KL; Crews DC; Cushman M; Yuan Y; Wilkinson K; Long DL; Judd SE; Shlipak MG; Ix JH; Bullen AL; Warnock DG; Gutiérrez OM
Am J Kidney Dis; 2023 Jul; 82(1):11-21.e1. PubMed ID: 36621640
[TBL] [Abstract][Full Text] [Related]
6. Risk Prediction for Early CKD in Type 2 Diabetes.
Dunkler D; Gao P; Lee SF; Heinze G; Clase CM; Tobe S; Teo KK; Gerstein H; Mann JF; Oberbauer R;
Clin J Am Soc Nephrol; 2015 Aug; 10(8):1371-9. PubMed ID: 26175542
[TBL] [Abstract][Full Text] [Related]
7. Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC Study.
de Boer IH; Gao X; Cleary PA; Bebu I; Lachin JM; Molitch ME; Orchard T; Paterson AD; Perkins BA; Steffes MW; Zinman B;
Clin J Am Soc Nephrol; 2016 Nov; 11(11):1969-1977. PubMed ID: 27797889
[TBL] [Abstract][Full Text] [Related]
8. Black and White Adults With CKD Hospitalized With Acute Kidney Injury: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
Muiru AN; Yang J; Derebail VK; Liu KD; Feldman HI; Srivastava A; Bhat Z; Saraf SL; Chen TK; He J; Estrella MM; Go AS; Hsu CY;
Am J Kidney Dis; 2022 Nov; 80(5):610-618.e1. PubMed ID: 35405207
[TBL] [Abstract][Full Text] [Related]
9. Diabetic kidney disease and risk of incident stroke among adults with type 2 diabetes.
Kaze AD; Jaar BG; Fonarow GC; Echouffo-Tcheugui JB
BMC Med; 2022 Mar; 20(1):127. PubMed ID: 35346165
[TBL] [Abstract][Full Text] [Related]
10. Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD.
Bowe B; Xie Y; Xian H; Li T; Al-Aly Z
Clin J Am Soc Nephrol; 2017 Apr; 12(4):603-613. PubMed ID: 28348030
[TBL] [Abstract][Full Text] [Related]
11. Rate of kidney function decline and factors predicting progression of kidney disease in type 2 diabetes mellitus patients with reduced kidney function: A nationwide retrospective cohort study.
Kaewput W; Thongprayoon C; Chewcharat A; Rangsin R; Satirapoj B; Kaewput C; Suwannahitatorn P; Bathini T; Mao MA; Cato LD; Harrison AM; Vaitla P; Cheungpasitporn W
Ther Apher Dial; 2020 Dec; 24(6):677-687. PubMed ID: 31997551
[TBL] [Abstract][Full Text] [Related]
12. Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
Heerspink HJL; Jongs N; Chertow GM; Langkilde AM; McMurray JJV; Correa-Rotter R; Rossing P; Sjöström CD; Stefansson BV; Toto RD; Wheeler DC; Greene T;
Lancet Diabetes Endocrinol; 2021 Nov; 9(11):743-754. PubMed ID: 34619108
[TBL] [Abstract][Full Text] [Related]
13. Racial and ethnic variations in albuminuria in the US Third National Health and Nutrition Examination Survey (NHANES III) population: associations with diabetes and level of CKD.
Bryson CL; Ross HJ; Boyko EJ; Young BA
Am J Kidney Dis; 2006 Nov; 48(5):720-6. PubMed ID: 17059991
[TBL] [Abstract][Full Text] [Related]
14. Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
Jongs N; Greene T; Chertow GM; McMurray JJV; Langkilde AM; Correa-Rotter R; Rossing P; Sjöström CD; Stefansson BV; Toto RD; Wheeler DC; Heerspink HJL;
Lancet Diabetes Endocrinol; 2021 Nov; 9(11):755-766. PubMed ID: 34619106
[TBL] [Abstract][Full Text] [Related]
15. Changes in Albuminuria and Subsequent Risk of Incident Kidney Disease.
Sumida K; Molnar MZ; Potukuchi PK; George K; Thomas F; Lu JL; Yamagata K; Kalantar-Zadeh K; Kovesdy CP
Clin J Am Soc Nephrol; 2017 Dec; 12(12):1941-1949. PubMed ID: 28893924
[TBL] [Abstract][Full Text] [Related]
16. Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.
Shimizu M; Furuichi K; Toyama T; Funamoto T; Kitajima S; Hara A; Ogawa D; Koya D; Ikeda K; Koshino Y; Kurokawa Y; Abe H; Mori K; Nakayama M; Konishi Y; Samejima KI; Matsui M; Yamauchi H; Gohda T; Fukami K; Nagata D; Yamazaki H; Yuzawa Y; Suzuki Y; Fujimoto S; Maruyama S; Kato S; Naito T; Yoshimura K; Yokoyama H; Wada T;
Clin Exp Nephrol; 2018 Apr; 22(2):377-387. PubMed ID: 28889347
[TBL] [Abstract][Full Text] [Related]
17. Diabetes, Kidney Disease, and Cardiovascular Outcomes in the Jackson Heart Study.
Afkarian M; Katz R; Bansal N; Correa A; Kestenbaum B; Himmelfarb J; de Boer IH; Young B
Clin J Am Soc Nephrol; 2016 Aug; 11(8):1384-1391. PubMed ID: 27340284
[TBL] [Abstract][Full Text] [Related]
18. Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study.
Molitch ME; Steffes M; Sun W; Rutledge B; Cleary P; de Boer IH; Zinman B; Lachin J;
Diabetes Care; 2010 Jul; 33(7):1536-43. PubMed ID: 20413518
[TBL] [Abstract][Full Text] [Related]
19. Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death.
Berhane AM; Weil EJ; Knowler WC; Nelson RG; Hanson RL
Clin J Am Soc Nephrol; 2011 Oct; 6(10):2444-51. PubMed ID: 21852671
[TBL] [Abstract][Full Text] [Related]
20. The kidney and cardiovascular outcome trials.
Bloomgarden Z
J Diabetes; 2018 Feb; 10(2):88-89. PubMed ID: 29031006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
